BioCentury
ARTICLE | Company News

AstraZeneca, Clinigen Group sales and marketing update

February 16, 2015 8:00 AM UTC

Clinigen launched an international global access program for AstraZeneca’s CAZ-AVI. CAZ-AVI is a third-generation cephalosporin combined with avibactam, a broad-spectrum beta lactamase (LACTB) inhib...